<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM MEDIMMUNE, INC.'S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1996 AND IS QUALIFIED IN ITS ENTIRETY TO REFERENCE TO SUCH FILING. </LEGEND> <MULTIPLIER>1,000 <PERIOD-TYPE> YEAR <FISCAL-YEAR-END> DEC-31-1996 <PERIOD-END> DEC-31-1996 <CASH> 12,629 <SECURITIES> 102,136 <RECEIVABLES> 10,287 <ALLOWANCES> 0 <INVENTORY> 6,060 <CURRENT-ASSETS> 1,713 <PP&E> 29,087 <DEPRECIATION> 0 <TOTAL-ASSETS> 163,971 <CURRENT-LIABILITIES> 19,536 <BONDS> 70,874 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 218 <OTHER-SE> 72,647 <TOTAL-LIABILITY-AND-EQUITY> 163,971 <SALES> 35,782 <TOTAL-REVENUES> 41,099 <CGS> 19,678 <TOTAL-COSTS> 74,035 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 2,263 <INCOME-PRETAX> (29,544) <INCOME-TAX> 0 <INCOME-CONTINUING> (29,544) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (29,544) <EPS-PRIMARY> (1.41) <EPS-DILUTED> (1.41)